Healthcare financing startup Icanheal has successfully raised ₹15 crore in a seed round of funding from IvyCap Ventures. The fresh capital will be utilized to bolster the company’s efforts in providing tailored healthcare financing solutions, especially for patients dealing with critical diseases such as cancer.
“Healthcare in India is rapidly evolving, and our platform is focused on making advanced treatments more affordable and accessible to all patients. This funding will enable us to expand our operations and advance our mission of enhancing healthcare outcomes nationwide,” said Girish Poddar and Amit Backliwal, Founders of Icanheal.
Icanheal is committed to democratizing healthcare solutions by offering features such as easy-to-pay instalments and claims reimbursement. The company believes these solutions will significantly improve accessibility, promote better adherence to treatments, and ultimately enhance overall patient outcomes.
Founded in 2011, IvyCap Ventures has a diverse portfolio, having invested in approximately 50 companies across various sectors, including health-tech, consumer-tech, deep-tech, fintech, edtech, agri-tech, and space-tech. On April 30, IvyCap Ventures announced the final close of its third fund at ₹2,100 crore. With this new fund, the firm plans to invest in around 25 early-stage startups.